8 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Multiple and single binding modes of fragment-like kinase inhibitors revealed by molecular modeling, residue type-selective protonation, and nuclear overhauser effects.
Bristol Myers Squibb Research and Development
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists.
Bristol Myers Squibb Research and Development
Discovery of Non-Nucleotide Small-Molecule STING Agonists
Bristol Myers Squibb Research and Development
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype.
Bristol Myers Squibb Research and Development
Conformational-Analysis-Guided Discovery of 2,3-Disubstituted Pyridine IDO1 Inhibitors.
Bristol Myers Squibb Research and Development
Development of BET inhibitors as potential treatments for cancer: A search for structural diversity.
Bristol Myers Squibb Research and Development
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy.
Bristol Myers Squibb Research and Development